Detecting drugs that cause thrombocytopenia: A comparison of published case reports and data mining of the USFDA adverse event reporting system (AERS) database.

被引:0
|
作者
Li, Xiaoning [1 ]
Terrell, Deirdra R. [1 ]
George, James N. [1 ]
Vesely, Sara K. [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
462
引用
收藏
页码:140A / 141A
页数:2
相关论文
共 50 条
  • [21] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Lianhui Wei
    Ye Tian
    Xiao Chen
    Xiaojing Guo
    Chenxin Chen
    Yi Zheng
    Jinfang Xu
    Xiaofei Ye
    [J]. International Journal of Clinical Pharmacy, 2023, 45 : 622 - 629
  • [22] Data mining and analysis for emicizumab adverse event signals based on the Food and Drug Administration Adverse Event Reporting System database
    Wei, Lianhui
    Tian, Ye
    Chen, Xiao
    Guo, Xiaojing
    Chen, Chenxin
    Zheng, Yi
    Xu, Jinfang
    Ye, Xiaofei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (03) : 622 - 629
  • [23] Atezolizumab and severe cutaneous adverse reactions: Data mining of the FDA Adverse Event Reporting System (FAERS) database
    Pecere, A.
    Bisinella, G. C.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1251 - S1251
  • [24] Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
    Sakaeda, Toshiyuki
    Kadoyama, Kaori
    Yabuuchi, Hiroaki
    Niijima, Satoshi
    Seki, Kyoko
    Shiraishi, Yukinari
    Okuno, Yasushi
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2011, 8 (04): : 332 - 338
  • [25] Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
    Zhang, Sha
    Wang, Yidong
    Qi, Zhan
    Tong, Shanshan
    Zhu, Deqiu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (02) : 471 - 479
  • [26] Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
    Sha Zhang
    Yidong Wang
    Zhan Qi
    Shanshan Tong
    Deqiu Zhu
    [J]. International Journal of Clinical Pharmacy, 2024, 46 : 471 - 479
  • [27] Drug-Induced Gynecomastia: Data Mining and Analysis of the FDA Adverse Event Reporting System Database
    Yang, Xiuli
    Zheng, Xiaochun
    Zhang, Miaomiao
    Huang, Jinlong
    Huang, Ping
    Wang, Jiangfeng
    [J]. CLINICAL EPIDEMIOLOGY, 2024, 16 : 617 - 630
  • [28] Aspirin- and Clopidogrel-associated Bleeding Complications: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
    Tamura, Takao
    Sakaeda, Toshiyuki
    Kadoyama, Kaori
    Okuno, Yasushi
    [J]. INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2012, 9 (06): : 441 - 446
  • [29] Thrombocytopenia after vaccination: Case reports to the US Vaccine Adverse Event Reporting System, 1990-2008
    Woo, Emily Jane
    Wise, Robert P.
    Menschik, David
    Shadomy, Sean V.
    Iskander, John
    Beeler, Judy
    Varricchio, Frederick
    Ball, Robert
    [J]. VACCINE, 2011, 29 (06) : 1319 - 1323
  • [30] Post-marketing pharmacovigilance study of inclisiran: mining and analyzing adverse event data from the FDA Adverse Event Reporting System database
    Zou, Dan
    Hu, Qiaozhi
    Liu, Ying
    Yu, Lei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024,